INmune Bio, Inc. filed an offering with the Securities and Exchange Commission (Bangladesh) on June 28, 2025, utilizing Global Partners as the sole placement agent.
2 reports, 0 independent
Updated Jun 28
Gone quiet
- Reports
- 2
- Developments
- 2
- Repetition
- 0%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
INmune Bio, Inc. filed an offering with the Securities and Exchange Commission (Bangladesh) on June 28, 2025, utilizing Global Partners as the sole placement agent.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.- INmune Bio files offering with SEC (Bangladesh), Global Partners as placement agent.
- Reviva Pharmaceuticals filed an offering with SEC Bangladesh via Global Partners.
Keep exploring
The entities involved
-
Securities and Exchange Commission (Bangladesh)
government regulatory body overseeing the stock market
-
Global Partners
American energy supply company
Coverage
Newest first; wire copies grouped- Unknown outlet
- Unknown outlet